Skip to content Skip to footer
Subscribe Now
Insights+: The US FDA New Drug Approvals in August 2023
INSIGHTS+

The US FDA New Drug Approvals in March 2025

Shots:      PharmaShots has compiled a list of US FDA-approved drugs in the month of March 2025       The US FDA has approved a total of 2 new drug including 2 new molecular entities leading to the treatment of patients and advances in the healthcare industry        The major highlighted drug was GSK’s Blujepa securing approval for treating…
April 15, 2025

Read more

CXO TALKS

CXO Talks: Ali Jannati from Linus Health in a Stimulating Dialogue Exchange with PharmaShots

In the CXO Talks podcast, PharmaShots spoke with Ali Jannati, Director of Cognitive Science at Linus Health. Ali eloquently highlighted Linus’ journey to becoming a leader in digital brain health through its innovative digital cognitive assessment platform He emphasized the importance of digital biomarkers in evaluating brain function by capturing subtle nuances and response latencies,…
April 14, 2025

Read more

Announcements

PharmaShots Announces Strategic Data Partnership with AlphaSense 

PharmaShots is pleased to announce a new strategic data partnership with AlphaSense, marking an important milestone in our mission to elevate the quality, accessibility, and impact of insights across the biopharma and healthcare ecosystem.  This collaboration strengthens our commitment to reimagining intelligence and delivering unmatched industry updates that empower researchers, students, analysts, and biopharma professionals worldwide. By…
April 13, 2025

Read more

PharmaShots Magazine-April-2025 Edition
MAGAZINE

PharmaShots Magazine-April-2025 Edition

Emerging technologies holds a promising foothold in redefining the aspects of preventative, diagnostic, therapeutic, and patient care in the healthcare landscape. 3D Bioprinting offers innovative approach to addressing unmet healthcare needs with efficacious precision medicine in life-threatening conditions and developing therapies and medical devices that mimic complex human physiology.  In April, PharmaShots Magazine is exploring…
April 10, 2025

Read more

Spotlight Interview_Nazeen Rahman
EVENTS

Reuters Pharma 2025: Pre-Conference Talks Featuring Nazneen Rahman

In this thought-provoking Podcast, Nazneen Rahman Founder and CEO of YewMaker shares a glimpse of her upcoming presentation at the Reuters Pharma 2025 event on “Accelerate Access to Medicine: Unite for Global Health Equity” Nazneen talks about fostering science-based scalable solutions to promote sustainability in the biopharma industry. PharmaShots was delighted to learn about YewMaker’s…
April 8, 2025

Read more

Spotlight Interview_Ana Cerdeira
EVENTS

Reuters Pharma 2025: Pre-Conference Talks Featuring Ana Cerdeira

Ana Cerdeira, Vice President, Global Head Commercial, Development Assets, Innovative Medicines Group, Grunenthal in a stimulating conversation with PharmaShots’ Managing Director Himanshu Sehgal. Ana will be joining the upcoming Reuters Events Pharma 2025 as a panelist for the topic “Value unleashed: Elevate patient, HCP, and payer engagement with holistic storytelling tools and RWE”. In this…
April 8, 2025

Read more

Key Biosimilars Events of March 2025
INSIGHTS+

Key Biosimilars Events of March 2025

Shots:        Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency         Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and patients         Bio-Thera Collaborates with Dr. Reddy’s for the Commercialization of BAT2206 & BAT2506…
April 8, 2025

Read more

Spotlight Interview_Philippe Barillon
EVENTS

Reuters Pharma 2025: Pre-Conference Talks Featuring Philippe Barillon

Philippe Barillon joins PharmaShots Managing Editor Himanshu Sehgal for an enlightening dialogue exchange in a Pre-Conference Talk. Philippe will be joining the upcoming Reuters Events Pharma 2025 as a panelist for the topic “Bridging gaps: Leverage data, tech and RWE for enhanced healthcare access and market growth”. Philippe highlights the potential applications of RWEs using…
April 7, 2025

Read more

Viewpoints_Raphaël Ortiz
VIEWPOINTS

Enhancing Diagnostic Capabilities in Prostate Cancer: Raphaël Ortiz from Telix Pharmaceuticals in a Riveting Conversation with PharmaShots

Shots:  Telix Pharmaceuticals’ Illuccix is approved in the UK for detecting and localizing prostate-specific membrane antigen (PSMA)-positive lesions in adults with prostate cancer, using PET imaging.  Amidst a shortage of PET imaging agents in the UK and mainland Europe, Telix Pharmaceuticals has secured a significant advantage through an exclusive distribution partnership with Xiel Limited  Raphaël…
April 7, 2025

Read more

Load more